However, a study by Lee et al. revealed that EMAST CRCs show enrichment of CD8+ T cells, but not CD4+ T cells, in the tumor center and surrounding stroma, a feature usually associated with better prognosis in CRC [51]. This evidence concerns the gene CD8A and colorectal carcinoma.